Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Echocardiography ; 36(1): 192-195, 2019 01.
Article de Anglais | MEDLINE | ID: mdl-30460782

RÉSUMÉ

Double-chambered left ventricle (DCLV) is an extremely rare congenital heart disease. In this condition, the left ventricle is divided into two chambers by a septum or muscle fiber with abnormal proliferation. A symptomatic boy was diagnosed with DCLV at our hospital. The patient was admitted with the major complaint of 8 years of cardiac murmur, which was discovered through physical examination, and 5 years of palpitations and shortness of breath. He has been followed up without treatment.


Sujet(s)
Échocardiographie/méthodes , Cardiopathies congénitales/imagerie diagnostique , Ventricules cardiaques/malformations , Ventricules cardiaques/imagerie diagnostique , Enfant , Diagnostic différentiel , Humains , Mâle
2.
J Cardiothorac Surg ; 12(1): 17, 2017 Mar 27.
Article de Anglais | MEDLINE | ID: mdl-28347347

RÉSUMÉ

BACKGROUND: Cardiac myxoma is the most common primary cardiac tumor. Approximately 75-80% of myxomas are located in the left atrium. Occurrence of multiple myxomas is extremely rare. CASE PRESENTATION: We describe a rare case of biventricular myxomas resulting in right ventricular inflow and tricuspid valve obstruction. The lesions were detected by echocardiography and thoracic computerized tomography (CT) and confirmed on positron emission tomography-computed tomography. CONCLUSION: The patient underwent successful surgical resection of the multiple cardiac myxomas. This kind of biventricular case has not been previously reported. The patient is asymptomatic as of the 10-month follow-up.


Sujet(s)
Procédures de chirurgie cardiaque/méthodes , Tumeurs du coeur/chirurgie , Myxome/chirurgie , Adolescent , Échocardiographie , Femelle , Tumeurs du coeur/diagnostic , Ventricules cardiaques , Humains , Myxome/diagnostic , Tomographie par émission de positons couplée à la tomodensitométrie , Tomodensitométrie
3.
Zhonghua Yi Xue Za Zhi ; 89(22): 1577-81, 2009 Jun 09.
Article de Chinois | MEDLINE | ID: mdl-19953890

RÉSUMÉ

OBJECTIVE: To investigate the possibilities of human mesenchymal stem cells (hMSCs) migrating toward the oxidative stress injuries of endothelial cells. METHODS: hMSCs were isolated and cultured from human marrow in vitro and the multipotential differentiation of P3 hMSCs identified by specific medium induced to differentiate into osteoblasts, adipocytes and endothelial cells. And the marker antigen of P3 hMSCs was detected by flow cytometry (FCM) and immunohistochemistry. Then a cellular model of hMSCs migrating toward the oxidative stress injuries of endothelial cells was created, i. e. 1 x 10(5) hMSCs were seeded in Transwell upper chamber, indirectly co-cultured with ECV-304 cells seeded in the Transwell inferior chamber and was injured by adding 3% H2O2 into the medium (final concentration of 0.01 ml/ml) for 1 h, the injured ECV-304 cells + hMSCs group (n = 8), as experimental group, and in the mean time, hMSCs indirectly co-cultured with uninjured ECV-304 cells in Transwell chamber, ECV-304 cells + hMSCs group (n = 8) and hMSCs monoculture group (n = 8) in Transwell chamber as control groups. After a 12-h culture in all groups, the migrating hMSCs in Transwell upper chamber were HE-stained and counted under an inverted phase contrast microscope. To understand the reason why hMSCs migrated to the oxidative stress injured endothelial cells, ELISA was employed to measure the concentration of monocyte chemoattractant protein-1 (MCP-1) and vascular cell adhesion molecule-1 (VCAM-1) of cellular supernatant in ECV-304 cells with H2O2 1-h treating group (H2O2 treatment group) or without H2O2 treating group (control group). RESULTS: The multipotential differentiation experiment demonstrated that the cultured P3 hMSCs can be induced to differentiate in vitro into osteoblasts, adipocytes and endothelial cells. And the expressions of CD29, CD44, CD90 and CD106 were positive in hMSCs while CD31, CD34, CD45 and CD49b negative by using FCM and immunohistochemistry. And the effects of hMSCs upon in vitro movement toward oxidative stress injuries of ECV-304 cells were averaged (8. 00 +/- 0.22) cells/HP in the injured ECV-304 cells + hMSCs group, significantly higher than those of the ECV-304 cells + hMSCs group [(0.20 +/- 0.05) cells/HP, P < 0.01] and the hMSCs monoculture group [(0.00 +/- 0.00) cells/HP, P < 0.01). The concentrations of MCP-1 and VCAM-1 in cellular supernatant of the H2O2 treatment group were significantly higher than those of the control group [(69.2 +/- 3.5) ng/ml vs (62.5 +/- 3.6) ng/ml, P < 0.05; (114.0 +/- 7.5) ng/ml vs (97.2 +/- 5.0) ng/ml, P < 0.01]. CONCLUSIONS: The oxidative stress injuries of endothelial cells chemoattracted the hMSCs toward the injured site and its mechanism may be correlated with releasing a certain concentration of chemoattractant factor to result in the elevations of MCP-1 and VCAM-1 by oxidative stress injury.


Sujet(s)
Chimiotaxie , Cellules endothéliales/cytologie , Cellules souches mésenchymateuses/cytologie , Stress oxydatif , Cellules de la moelle osseuse/cytologie , Différenciation cellulaire , Prolifération cellulaire , Cellules cultivées , Chimiokine CCL2/métabolisme , Cellules endothéliales/métabolisme , Endothélium vasculaire/cytologie , Humains , Cellules souches mésenchymateuses/métabolisme , Molécule-1 d'adhérence des cellules vasculaires/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE